NADK: A Key Enzyme in Cellular Processes (G65220)

Target Name: NADK

NCBI ID: G65220

NADK

NADK: A Key Enzyme in Cellular Processes

NADK (poly(P)/ATP NAD kinase) is a protein that plays a crucial role in the regulation of cellular processes. It is a key enzyme in the poly(P) metabolism, which is the process by which phosphate groups are added to nucleotides to form ADP and P. NADK is involved in the transfer of phosphate groups from the nucleotide to NAD+, which is then used to generate ATP.

NADK is a 21-kDa protein that is expressed in most tissues and cells. It is highly conserved, with only minor differences in its sequence between different species. NADK has four known subunits, which are encoded by the NADK gene. The subunits are located in different cellular organelles, including the cytoplasm, the mitochondria, the endoplasmic reticulum, and the nuclear envelope.

NADK is involved in many cellular processes that are essential for cell survival. For example, it is involved in the regulation of DNA replication, transcription, and translation. NADK is also involved in the regulation of cell signaling pathways, including the DNA-protein binding, cell signaling, and cell growth.

One of the unique features of NADK is its role in the regulation of poly(P) metabolism. Poly(P) is a nucleotide that contains a phosphate group, which can be added to the nucleotide through various metabolic pathways. NADK is the enzyme that transfers the phosphate group from the nucleotide to NAD+, which is then used to generate ATP. This process is essential for the growth and development of all cells.

NADK is a potential drug target and may be a biomarker for certain diseases. For example, NADK has been shown to be involved in the regulation of cellular processes that are affected by many diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

In addition to its role in cellular processes, NADK is also a potential therapeutic agent. The NADK inhibitors, which are designed to inhibit the activity of NADK, have been shown to have therapeutic potential in various diseases. For example, NADK inhibitors have been shown to be effective in treating cancer, neurodegenerative diseases, and cardiovascular diseases.

In conclusion, NADK is a protein that plays a crucial role in the regulation of cellular processes. Its role in the regulation of poly(P) metabolism is essential for cell survival. NADK is also a potential drug target and may be a biomarker for many diseases. The inhibition of NADK activity may have therapeutic potential in the treatment of various diseases. Further research is needed to fully understand the role of NADK in cellular processes and its potential as a therapeutic agent.

Protein Name: NAD Kinase

The "NADK Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NADK comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets